Ingredion Ventures
Overview
Ingredion Ventures is the corporate venture capital arm of Ingredion Incorporated, investing in innovative start-ups with disruptive products, technology, and sustainable business models in the food and agricultural technology sectors.
Portfolio Companies
2
Website
ingredion.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oobli | Feb 2025 | Series B Extension | Lead |
For institutional investors. Book with your work email.
Key People
Mauro Merino
TA Partner US CAN Associate Recruiting
Avni Jayswal
Sr. Portfolio Manager, Office of the CIO
CPSM Barbara F. Holcomb
Sr. Director, Office Of The CDIO, Global Finance And HR Digital Partner
Emma Topps
Principal Technologist
Jayesh Fadia
Principal Technician
Katelyn Meyler
Principal Technologist
Kylee Mai
Principal Technologist
Peter DeMartino
Principal R&D Chemist
Quyen Nguyen
Principal Food Technologist
Shalom Alabi
Principal Technician
Shuo Lun Kng
Principal Technologist
Sunil Dev
Sr. Principal-Supply Chain
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ingredion Ventures based?
Ingredion Ventures is headquartered in Westchester, Illinois, United States.
When was Ingredion Ventures founded?
Founding year information for Ingredion Ventures is not publicly available.
How many portfolio companies does Ingredion Ventures have?
Ingredion Ventures has 2 portfolio companies in Caplight's dataset.
What are some companies in Ingredion Ventures's portfolio?
Portfolio companies visible on Caplight include Oobli.
What was Ingredion Ventures's most recent investment shown here?
Ingredion Ventures's most recent investment in this portfolio sample was in Oobli in 2025.
What sectors does Ingredion Ventures focus on?
Ingredion Ventures focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Ingredion Ventures focus on?
Ingredion Ventures typically invests at the Early stage.